Search - tctmd.com

Displaying 1 - 20 of 95

Sort: Relevancy | Date

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures

L.A. McKeown

December 08, 2017

News Daily News

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

Caitlin E. Cox

December 05, 2017

News Daily News

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

Yael L. Maxwell

December 01, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

News Conference News AHA 2017

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

Shelley Wood

November 09, 2017

News Conference News TCT 2017

CrossBoss First Shows Promise for Antegrade CTO PCI

TCT Daily Staff

November 07, 2017

Presentation TCT 2017

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

Presenter: Peter P. Monteleone, Thomas M. Tu, Jay S. Giri

November 01, 2017

Presentation TCT 2017

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

Presenter: Robert-Jan van Geuns, Emmanouil S. Brilakis

October 31, 2017

Presentation TCT 2017

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Presenter: Martin B. Leon, Patrick T. O'Gara, Olaf Wendler

October 30, 2017

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Gennaro Giustino

October 30, 2017

Presentation TCT 2017

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? Yes, Based on TROPICAL-ACS, TRITON, and Other Studies!

Presenter: John A. Bittl, Freek W.A. Verheugt, Dirk Sibbing

October 30, 2017

Presentation TCT 2017

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Presenter: Anthony N. DeMaria, Francisco Fdez-Aviles, Jens Kastrup

October 30, 2017

Presentation TCT 2017

Case #6: Escalation of Mechanical Circulatory Support Devices in Cardiogenic Shock (With Discussion)

Presenter: Timothy D. Henry, Thomas D. Stuckey, Sandeep Nathan

October 30, 2017

Presentation TCT 2017

Case #3: CTO Wire Escalation Strategy for Antegrade Crossing of a Difficult Tibial CTO (With Discussion)

Presenter: Robert A. Lookstein, Jihad A. Mustapha, Peter A. Soukas

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

Presentation TCT 2017

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Presenter: Jeroen J. Bax, Axel Linke, Alec S. Vahanian

October 29, 2017

News Daily News

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Michael O'Riordan

October 17, 2017

News Features

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Todd Neale

October 16, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

Advertisement

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures

Myocardial Injury After Noncardiac Surgery Linked With Higher 1-Year Mortality

More Headaches: PREMIUM’s Publication Renews Debate Over PFO Closure for Migraine

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

AHA 2017: New Hypertension Guidelines, COMPASS Costs, Dual Drug Dilemmas, and More

CrossBoss First Shows Promise for Antegrade CTO PCI

Beyond Heparin: When and How to Escalate Therapy for Acute PE (Lytics, Catheter-Based, Surgery)

CrossBoss First: A Randomized Trial of Antegrade Dissection and Re-entry vs Standard Wire Escalation for Crossing Coronary Artery Chronic Total Occlusions

Insights From the New 2017 ESC Valve Disease Guidelines: Changes in the Management of Aortic Stenosis

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? No, Based on HORIZONS-AMI, PLATO, PEGASUS, and Other Studies!

Debate: After PCI in ACS, Should DAPT Potency Be De-escalated Over Time? Yes, Based on TROPICAL-ACS, TRITON, and Other Studies!

The European Vision of Regenerative Cardiovascular Medicine: The New CARE Working Group of the ESC

Case #6: Escalation of Mechanical Circulatory Support Devices in Cardiogenic Shock (With Discussion)

Case #3: CTO Wire Escalation Strategy for Antegrade Crossing of a Difficult Tibial CTO (With Discussion)

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

TAVR vs SAVR: What Do the 2017 ESC Guidelines Say?

Absorb BVS Again Linked to Scaffold Thrombosis at 1 Year and Beyond

Conference Organizers, Physicians Wary as Direct Industry Sponsorship Winds Down in Europe

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content